Boston Family Office’s Teladoc Health TDOC Stock Holding History

Boston Family Office’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,520	Closed	-$398K	–	284
2022 Q1	$398K	Hold	5,520	–	–	0.03%	225
2021 Q4	$507K	Hold	5,520	–	–	0.03%	212
2021 Q3	$700K	Hold	5,520	–	–	0.05%	182
2021 Q2	$918K	Buy	5,520 +100	+2%	+$16.2K	0.07%	168
2021 Q1	$985K	Sell	5,420 -500	-8%	-$116K	0.07%	162
2020 Q4	$1.18M	Buy	+5,920	New	+$1.2M	0.09%	148

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Boston Family Office's TDOC Position: Q2 2022 in Review

Boston Family Office sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 5,520 shares — an estimated $398K sold.

Boston Family Office first reported a position in TDOC in Q4 2020 and held it in 6 quarters. The position peaked at $1.18M in Q4 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

Boston Family Office reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
Boston Family Office sold 5,520 Teladoc Health shares in Q2 2022, an estimated $398K.
Boston Family Office first reported a position in Teladoc Health in Q4 2020 and held it in 6 quarters.
Boston Family Office's Teladoc Health position peaked at $1.18M in Q4 2020.
550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Boston Family Office's 13F filing for Q2 2022, filed 11 Aug 2022.